The world-renowned Weill Cornell Lymphoma Program is dedicated to delivering the most advanced treatment and comprehensive care for people with lymphoma, including those with all types of Hodgkin lymphoma and non-Hodgkin lymphoma, as well as chronic lymphocytic leukemia (CLL). Learn more about our sub-specialty program specifically dedicated to caring for people with CLL.
For decades, our program has been leading the research revolution that is helping patients live longer and feel better. We view each person as an individual, and our multidisciplinary approach ensures that each treatment regimen is narrowly tailored to meet the unique needs of each of our patients and their families.
We have developed an outstanding multidisciplinary team that includes medical oncologists, hematologists, radiation oncologists, surgeons, radiologists, pathologists, transplant physicians, nurses and other healthcare professionals. Together with leading experts in primary care, infectious diseases, pulmonary medicine, cardiology, surgery, and all other medical specialties at Weill Cornell Medicine, we provide complete care for all ongoing and future medical needs.
A cancer diagnosis can affect your whole life, and we recognize that people living with lymphoma have needs that extend beyond just receiving the best medical treatment. We provide access to nutritional guidance, counselors, support groups, patient navigators, and more.
Our team of nationally and internationally recognized lymphoma experts is known for advanced work and published research in:
- Precisely targeted treatments with fewer side effects than chemotherapy and radiation
- Novel treatments for advanced and aggressive forms of lymphoma
- Lymphoma biology, genetics, and personalized medicine
- Caring for special populations, such as adolescent, young adult and geriatric patients with lymphoma
- The psychosocial impact of lymphoma
We pride ourselves on exceptional outcomes, and we offer the most advanced diagnostic methods and treatments – whether you’re newly diagnosed or have a previously treated lymphoma. These include:
- Targeted therapies
- Oral therapies
- Stem cell transplantation
Our program has a substantial focus on treating lymphoma using the most promising novel agents, often years before they become widely available. Through our clinical trials and research labs, we have helped develop breakthrough lymphoma treatments, including nearly every lymphoma drug that the Food and Drug Administration (FDA) has approved since 2000. We offer clinical trials for Hodgkin lymphoma and virtually every subtype of non-Hodgkin lymphoma, including:
- Chronic lymphocytic leukemia/small lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Follicular lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- T-cell lymphomas
- Waldenstrom’s Macroglobulinemia
In concert with your referring physician, we are always available to offer a second opinion in the form of a consultation with one of our specialists. We frequently work with cancer doctors outside of New York City to help provide expert care.
Why Choose Us?
People living with lymphoma in New York City, throughout the United States, and around the world come to the Weill Cornell Lymphoma Program because we provide the most cutting-edge diagnostics and state-of-the-art treatment methods.
We are also committed to moving the field forward through medical advances with the potential to alleviate the suffering from lymphoma in the future.
For more information about the Weill Cornell Lymphoma Program’s latest research and activities, please visit our blog: “New Developments in Lymphoma.”
For more information or to schedule an appointment, call us at (646) 962-2064.
Weill Cornell Medical College is ranked among the nation’s best by U.S. News & World Report year after year.